摘要
目的 探讨血清心型脂肪酸结合蛋白(H-FABP)、血管生成素-1(Ang-1)在急性大血管闭塞性卒中(AIS-LVO)静脉溶栓桥接支架取栓患者预后中的评估价值。方法 选择2019年1月—2021年5月80例AIS-LVO患者作为研究对象,均接受静脉溶栓桥接支架取栓治疗,检测术前血清H-FABP、Ang-1水平,术后随访90 d将患者分为预后良好组(n=57)与预后不良组(n=23)。结果 两组在高血压、冠心病、心房颤动、急性卒中治疗低分子肝素试验(TOAST)分型、侧支循环、术前H-FABP、术前Ang-1方面存在差异(P<0.05)。多因素Logistic回归分析结果显示,高血压、心房颤动、心源性梗死型、侧支循环为0~1级、术前H-FABP≥10.0 ng/L、术前Ang-1<5.25 ng/mL是AIS-LVO静脉溶栓桥接支架取栓患者预后不良的危险因素。术前血清H-FABP预测术后90 d预后不良的AUC为0.728(95%CI:0.368~0.918),灵敏度、特异度分别为66.68%、58.92%。术前血清Ang-1预测术后90 d预后不良的AUC为0.773(95%CI:0.592~1.129),灵敏度、特异度分别为70.35%、63.92%。H-FABP联合Ang-1预测术后90 d预后不良的AUC为0.854(95%CI:0.652~0.957),灵敏度、特异度分别为77.18%、71.82%。结论 静脉溶栓桥接支架取栓治疗AIS-LVO患者的预后受到多种危险因素的影响,其中术前血清H-FABP和Ang-1是具有前景的预后预测因子。
Objective To investigate the prognostic value of serum heart-type fatty acid binding protein(H-FABP)and angiopoietin-1(Ang-1)in patients with acute ischemic stroke-large vessel occlusion(ALS-LVO)undergoing venous thrombolytic bridging stent thrombectomy.Methods A total of 80 patients with ALS-LVO from January 2019 to May 2021 were selected as the study subjects,treated with intravenous thrombolytic bridging stent thrombectomy,and their serum H-FABP and Ang-1 levels were measured before operation.After 90 days of follow-up,the patients were divided into good prognosis group(n=57)and poor prognosis group(n=23).Results There were significant differences between the two groups in hypertension,coronary heart disease,atrial fibrillation,TOAST classification,collateral circulation,preoperative H-FABP,and preoperative Ang-1(P<0.05).Multivariate logistic regression analysis showed that hypertension,atrial fibrillation,cardiogenic infarction type,collateral circulation of 0~1 grade,preoperative H-FABP≥10.0 ng/L,preoperative Ang-1<5.25 ng/mL were independent risk factors for poor prognosis of ALS-LVO patients treated with venous thrombolytic bridging stents.The AUC of preoperative serum H-FABP predicting poor prognosis 90 days after operation was 0.728(95%CI:0.368~0.918),with sensitivity and specificity of 66.68%and 58.92%respectively.The AUC of preoperative serum Ang-1 predicting poor prognosis 90 days after surgery was 0.773(95%CI:0.592~1.129),with sensitivity and specificity of 70.35%and 63.92%respectively.The AUC predicted by H-FABP combined with Ang-1 for poor prognosis 90 days after operation was 0.854(95%CI:0.652~0.957),and the sensitivity and specificity were 77.18%and 71.82%respectively.Conclusions The prognosis of patients with ALS-LVO treated with intravenous thrombectomy bridging stent thrombectomy is affected by many risk factors,among which preoperative serum H-FABP and Ang-1 are promising prognostic factors.
作者
吴肖锋
陈丽薇
张浩
WU Xiaofeng;CHEN Liwei;ZHANG Hao(Department of Neurology,Sanmenxia Hospital of Yellow River,Sanmenxia 472000,China)
出处
《广州医药》
2023年第8期40-45,共6页
Guangzhou Medical Journal
基金
中国水利水电第十一工程局有限公司科技项目[2021-(217)]。
关键词
急性大血管闭塞性卒中
心型脂肪酸结合蛋白
血管生成素-1
预后评估
静脉溶栓
桥接支架取栓
acute ischemic stroke-large vessel occlusion
heart type fatty acid binding protein
angiopoietin-1
prognostic evaluation
venous thrombolysis
bridging stent thrombectomy